Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
62.10
+0.70 (1.14%)
Oct 27, 2026, 12:00 PM CET

BME:ROVI Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
773.05743.48763.75829.51817.7648.68
Revenue Growth
3.21%-2.65%-7.93%1.44%26.06%54.46%
Gross Profit
500.42471.59467.71483.34512.43379.84
Operating Income
150.85173.14178.71219.47253.74180.15
Net Income
185.18140.44136.88170.34199.67153.08
Earnings Per Share
3.622.752.673.203.732.76
EPS Growth
39.93%2.73%-16.53%-14.25%35.31%150.36%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing
513.22494.13600.35644.41619.23471.79
Other
0.140.1----
Inter-Segment Transactions
-214.59-224.63-264.13-235.13-215.69-207.09
Marketing
474.29473.89427.53420.23414.15383.98
Total
773.05743.48763.75829.51817.7648.68

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
128.0798.628.0225.44125.0399.14
Total Debt
107.69121.82114.4165.4372.1773.16
Net Cash (Debt)
20.38-23.22-86.39-39.9952.8725.97
Net Cash Growth
----103.55%-
Net Cash Per Share
0.40-0.45-1.69-0.750.990.47

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
253.32187.08138.28113.25237.6149.44
Capital Expenditures
-73.93-65.21-59.12-53.79-50.72-40.22
Free Cash Flow
179.39121.8779.1659.45186.88109.22
Free Cash Flow Growth
138.23%53.95%33.15%-68.19%71.10%1348.77%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.73%63.43%61.24%58.27%62.67%58.55%
Operating Margin
19.51%23.29%23.40%26.46%31.03%27.77%
Pretax Margin
30.43%24.65%23.27%26.57%31.55%28.15%
Profit Margin
23.96%18.89%17.92%20.53%24.42%23.60%
FCF Margin
23.21%16.39%10.37%7.17%22.86%16.84%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9590.9590.9351.1041.2940.956
Dividend Per Share Growth
2.60%2.60%-15.28%-14.69%35.39%150.68%
Dividend Yield
1.54%1.51%1.49%1.78%3.59%1.27%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.1523.1323.5218.869.6427.03
Forward PE
19.8721.5819.0219.7612.7625.70
P/FCF Ratio
17.5126.6540.6854.0410.3037.89
PS Ratio
4.064.374.223.872.356.38